|  Help  |  About  |  Contact Us

Publication : Cancer-associated pathways and biomarkers of venous thrombosis.

First Author  Hisada Y Year  2017
Journal  Blood Volume  130
Issue  13 Pages  1499-1506
PubMed ID  28807983 Mgi Jnum  J:249604
Mgi Id  MGI:5923153 Doi  10.1182/blood-2017-03-743211
Citation  Hisada Y, et al. (2017) Cancer-associated pathways and biomarkers of venous thrombosis. Blood 130(13):1499-1506
abstractText  Cancer patients have an increased risk of venous thromboembolism (VTE). In this review, we summarize common and cancer type-specific pathways of VTE in cancer patients. Increased levels of leukocytes, platelets, and tissue factor-positive (TF(+)) microvesicles (MVs) are all potential factors that alone or in combination increase cancer-associated thrombosis. Patients with lung or colorectal cancer often exhibit leukocytosis. Neutrophils could increase VTE in cancer patients by releasing neutrophil extracellular traps whereas monocytes may express TF. Thrombocytosis is often observed in gastrointestinal, lung, breast, and ovarian cancer and this could decrease the threshold required for VTE. Soluble P-selectin has been identified as a biomarker of cancer-associated thrombosis in a general cancer population and may reflect activation of the endothelium. P-selectin expression by the endothelium may enhance VTE by increasing the recruitment of leukocytes. Studies in patients with pancreatic or brain cancer suggest that elevated levels of PAI-1 may contribute to VTE. Although elevated levels of TF(+) MVs have been observed in patients with different types of cancer, an association between TF(+) MVs and VTE has been observed only in pancreatic cancer. Podoplanin expression is associated with VTE in patients with brain cancer and may activate platelets. Future studies should measure multiple biomarkers in each cancer type to determine whether combinations of biomarkers can be used as predictors of VTE. A better understanding of the pathways that increase VTE in cancer patients may lead to the development of new therapies to reduce the morbidity and mortality associated with thrombosis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Authors

0 Bio Entities

0 Expression